Načítá se...

MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

BACKGROUND: A substantial impediment to progress in trials of new therapies in neuromuscular disorders is the absence of responsive outcome measures that correlate with patient functional deficits and are sensitive to early disease processes. Irrespective of the primary molecular defect, neuromuscul...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet Neurol
Hlavní autoři: Morrow, Jasper M, Sinclair, Christopher D J, Fischmann, Arne, Machado, Pedro M, Reilly, Mary M, Yousry, Tarek A, Thornton, John S, Hanna, Michael G
Médium: Artigo
Jazyk:Inglês
Vydáno: Lancet Pub. Group 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4672173/
https://ncbi.nlm.nih.gov/pubmed/26549782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(15)00242-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!